Zhejiang Wecome Pharmaceutical Company Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 631.18 million compared to CNY 621.79 million a year ago. Revenue was CNY 632.95 million compared to CNY 622.77 million a year ago. Net income was CNY 96.5 million compared to CNY 135.82 million a year ago. Basic earnings per share from continuing operations was CNY 0.6667 compared to CNY 1.1278 a year ago. Diluted earnings per share from continuing operations was CNY 0.6667 compared to CNY 1.1278 a year ago.